Aravive
$12.949876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$12.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.05 (+0.39%) Today
-$0.05 (-0.38%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell Aravive and other stocks, options, ETFs, and crypto commission-free!
About ARAV
Aravive, Inc. Common Stock, also called Aravive, is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Read More Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.
Employees
14
Headquarters
Houston, Texas
Founded
2008
Market Cap
193.45M
Price-Earnings Ratio
0.00
Dividend Yield
0.00
Average Volume
525.08K
High Today
$13.42
Low Today
$12.76
Open Price
$12.90
Volume
306.29K
52 Week High
$15.62
52 Week Low
$3.07
Collections
ARAV Earnings
-$0.61
-$0.50
-$0.38
-$0.27
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
—